UNIVERCELLS
Jose Castillo is an accomplished professional with extensive experience in the biosciences and biotechnology sectors. Currently serving as the CEO of Quantoom Biosciences since June 2021, Castillo has also co-founded and held the position of CTO at Univercells since February 2013. As the owner of STRIGIDAE since 2008, Castillo has maintained a strong entrepreneurial presence, while previously contributing as a board member at Ovizio Imaging Systems and holding directorial roles at Pall Life Sciences and ATMI. Castillo’s career began at GSK, where management of viral vaccines industrialization was a key responsibility. Educational qualifications include a PhD in Applied Sciences and Chemical Engineering from Université libre de Bruxelles and a degree in Entrepreneurship from Solvay Brussels School of Economics and Management.
UNIVERCELLS
1 followers
Univercells is a global life sciences company making biologics available to everyone. We operate as a campus of start-ups: five businesses solving different parts of the same puzzle - meeting global demand for bioproduction. Because it is not enough for a drug to exist. To change the world it must be accessible to everyone. Each division of affiliates operates a different part of the healthcare value chain, through a distinct business model: Exothera is a Contract Manufacturing and Development Organization (CDMO) for biologicals, mainly vaccines and viral vectors, with GMP production facilities in Belgium and offering process development and optimization services. https://exothera.world/. Unizima delivers international project management of technology transfer, alongside operational support services (quality, supply chain, digital) and bioproduction training programs, as well as care centers and diagnostics surveillance centers. https://unizima.com/. At Quantoom Biosciences, scientists, engineers and clinicians are committed to solve some of the biggest challenges facing mRNA-based vaccines and therapeutics by developing an end-to-end RNA Platform. This includes DNA and RNA manufacturing and formulation, along with critical reagent supply, from sequence to large-scale production. https://www.quantoom.com/. Thanks to a substantial knowledge of the pharmaceutical industry and a strong scientific background, RLM Consulting provides international regulatory affairs support at all stages of product development, from discovery research through preclinical and clinical testing, up to and beyond submission of the dossier for marketing authorization. http://www.rlmconsulting.be/.